Amedeo Smart

Free Medical Literature Service

 

Amedeo

Colorectal Neoplasms
  Free Subscription

27.05.2024

1 Ann Oncol
1 Ann Surg Oncol
2 BMC Cancer
1 BMC Gastroenterol
1 Br J Cancer
1 Br J Surg
1 Cancer Lett
1 Clin Res Hepatol Gastroenterol
1 Dis Colon Rectum
1 Eur J Cancer
12 Eur J Surg Oncol
2 Gastroenterology
2 Gastrointest Endosc
2 Int J Cancer
2 Int J Colorectal Dis
1 J Clin Oncol
1 J Natl Cancer Inst
1 J Surg Oncol
1 Oncology (Williston Park)
2 PLoS One
1 Proc Natl Acad Sci U S A


    Ann Oncol

  1. AMBROSINI M, Rousseau B, Manca P, Artz O, et al
    Immune checkpoint inhibitors for POLE or POLD1 proofreading-deficient metastatic colorectal cancer.
    Ann Oncol. 2024 May 3:S0923-7534(24)00104-2. doi: 10.1016/j.annonc.2024.
    >> Share


    Ann Surg Oncol

  2. JUDGE SJ, Ghalambor T, Cavnar MJ, Lidsky ME, et al
    Current Practices in Hepatic Artery Infusion (HAI) Chemotherapy: An International Survey of the HAI Consortium Research Network.
    Ann Surg Oncol. 2023;30:7362-7370.
    >> Share


    BMC Cancer

  3. WANG JY, Zhang XP, Zhou HK, Cai HX, et al
    The selective sponging of miRNAs by OIP5-AS1 regulates metabolic reprogramming of pyruvate in adenoma-carcinoma transition of human colorectal cancer.
    BMC Cancer. 2024;24:611.
    >> Share

  4. SHI X, Zhao X, Xue J, Jia E, et al
    Extracellular vesicle biomarkers in circulation for colorectal cancer detection: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:623.
    >> Share


    BMC Gastroenterol

  5. LI ZM, Zhou W, Feng L, Zhang HY, et al
    Predictive value of preoperative CT enhancement rate and CT perfusion parameters in colorectal cancer.
    BMC Gastroenterol. 2024;24:176.
    >> Share


    Br J Cancer

  6. ZWART K, van Nassau SCMW, van der Baan FH, Koopman M, et al
    Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab.
    Br J Cancer. 2024 May 20. doi: 10.1038/s41416-024-02711.
    >> Share


    Br J Surg

  7. GABRIELE R, Campagnol M, Iannone I, Sapienza P, et al
    Faecal occult blood and sigmoidoscopy data from the Italian national screening programme.
    Br J Surg. 2024;111:znae131.
    >> Share


    Cancer Lett

  8. LUN J, Zhang Y, Yu M, Zhai W, et al
    Circular RNA circHIPK2 inhibits colon cancer cells through miR-373-3p/RGMA axis.
    Cancer Lett. 2024;593:216957.
    >> Share


    Clin Res Hepatol Gastroenterol

  9. CAZENEUVE N, Bouche O, Leger J, Borg C, et al
    Visceral fat and clinical outcome in patients receiving first-line chemotherapy with bevacizumab for metastatic colorectal cancer.
    Clin Res Hepatol Gastroenterol. 2024 May 22:102380.
    >> Share


    Dis Colon Rectum

  10. BERIAN JR
    Research Perspective on: Impact of Multidisciplinary Prehabilitation Interventions on Postoperative Hospital Length of Stay and Functional Capacity in Patients Undergoing Resection of Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Dis Colon Rectum. 2024 May 24. doi: 10.1097/DCR.0000000000003375.
    >> Share


    Eur J Cancer

  11. ZWART WH, Temmink SJD, Hospers GAP, Marijnen CAM, et al
    Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial.
    Eur J Cancer. 2024;204:114044.
    >> Share


    Eur J Surg Oncol

  12. KIM S, Huh JW, Lee WY, Yun SH, et al
    Predicting survival in locally advanced rectal cancer with effective chemoradiotherapy response.
    Eur J Surg Oncol. 2024;50:108361.
    >> Share

  13. TEN CATE DWG, Molenaar CJL, Garcia RS, Bojesen RD, et al
    Multimodal prehabilitation in elective oncological colorectal surgery enhances postoperative functional recovery: A secondary analysis of the PREHAB randomized clinical trial.
    Eur J Surg Oncol. 2024;50:108270.
    >> Share

  14. DE GRAAFF MR, Klaase JM, Dulk MD, Buis CI, et al
    Outcomes of liver surgery: A decade of mandatory nationwide auditing in the Netherlands.
    Eur J Surg Oncol. 2024;50:108264.
    >> Share

  15. VAN HAM NCM, Glazemakers S, van der Ende-van Loon M, Nieuwenhuijzen GAP, et al
    Factors associated with one-year mortality after curative surgery for primary clinical T4 and locally recurrent rectal cancer in elderly patients.
    Eur J Surg Oncol. 2024;50:108259.
    >> Share

  16. GEFFEN EGMV, Nederend J, Sluckin TC, Hazen SJA, et al
    Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment.
    Eur J Surg Oncol. 2024;50:108307.
    >> Share

  17. MARJASUO ST, Lehtimaki TE, Koskenvuo LE, Lepisto AH, et al
    Impact of mesorectal extranodal tumor deposits in magnetic resonance imaging on outcome of rectal cancer patients.
    Eur J Surg Oncol. 2024;50:108337.
    >> Share

  18. CRIPPA J, Magistro C, Montroni I, Borroni G, et al
    Charting connections: A systematic review of colorectal surgery research networks.
    Eur J Surg Oncol. 2024;50:108322.
    >> Share

  19. ZHOU L, Zhang Z, Wang L
    Treatment of anterior resection syndrome: A systematic review and network meta-analysis.
    Eur J Surg Oncol. 2024;50:108336.
    >> Share

  20. HOOGTEIJLING TJ, Abu Hilal M, Zimmitti G, Aghayan DL, et al
    Impact of neoadjuvant chemotherapy on short-term outcomes after simple and complex minimally invasive minor hepatectomy for colorectal liver metastases: A propensity-score matched and coarsened exact matched study.
    Eur J Surg Oncol. 2024;50:108309.
    >> Share

  21. PETRELLI F, Arru M, Colombo S, Cavallone M, et al
    BRAF mutations and survival with surgery for colorectal liver metastases: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108306.
    >> Share

  22. DIETZ MV, Hannink G, Said I, van der Zant FA, et al
    Development of a prediction model for recurrence in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
    Eur J Surg Oncol. 2024;50:108294.
    >> Share

  23. KHAN JS, Piozzi GN, Rouanet P, Saklani A, et al
    Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.
    Eur J Surg Oncol. 2024;50:108308.
    >> Share


    Gastroenterology

  24. VAN DE SCHOOTBRUGGE-VANDERMEER, Toes-Zoutendijk E, de Jonge L, van Leerdam ME, et al
    When to Start, When to Stop With Colorectal Cancer Screening: A Cost-Effectiveness Analysis.
    Gastroenterology. 2024 May 16:S0016-5085(24)04919.
    >> Share

  25. WILSON N, Bilal M, Westanmo A, Gravely A, et al
    Prevalence of Sessile Serrated Lesions in Individuals With Positive Fecal Immunochemical Test Undergoing Colonoscopy: Results From a Large Nationwide Veterans Affairs Database.
    Gastroenterology. 2024;166:1170-1173.
    >> Share


    Gastrointest Endosc

  26. VERHOEVEN DA, Moons LMG, Koch AD, Hardwick JCH, et al
    It's all about time: evaluation of the updated Zhongshan colorectal endoscopic submucosal dissection model in Western endoscopic submucosal dissection practice.
    Gastrointest Endosc. 2024;99:1076-1078.
    >> Share

  27. LI L
    Accurate diagnosis of early-stage colorectal cancer solely through the use of nonmagnified endoscopic white-light images.
    Gastrointest Endosc. 2024;99:1076.
    >> Share


    Int J Cancer

  28. HOLTHUIJSEN DDB, van Roekel EH, Bours MJL, Ueland PM, et al
    Longitudinal associations of plasma kynurenines and ratios with fatigue and quality of life in colorectal cancer survivors up to 12 months post-treatment.
    Int J Cancer. 2024 May 23. doi: 10.1002/ijc.34992.
    >> Share

  29. WANG R, Lv C, Li D, Song Y, et al
    EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis.
    Int J Cancer. 2024 May 21. doi: 10.1002/ijc.35039.
    >> Share


    Int J Colorectal Dis

  30. ADAMES A, O'Brien DR, Kelly AR, Saltz LB, et al
    Penile-scrotal erythrodysesthesia among rectal cancer patients receiving fluoropyrimidine-based chemoradiation: a case report series.
    Int J Colorectal Dis. 2024;39:75.
    >> Share

  31. TOMINAGA T, Nonaka T, Takamura Y, Oishi K, et al
    Risk factors for pulmonary complications after colorectal cancer surgery: a Japanese multicenter study.
    Int J Colorectal Dis. 2024;39:76.
    >> Share


    J Clin Oncol


  32. Erratum: Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial.
    J Clin Oncol. 2024 May 22:JCO2400997. doi: 10.1200/JCO.24.00997.
    >> Share


    J Natl Cancer Inst

  33. HOCHSTER HS, Catalano P, Weitz M, Mitchell EP, et al
    Combining anti-VEGFR and anti-EGFR antibodies: Randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer:(ECOG-ACRIN E7208).
    J Natl Cancer Inst. 2024 May 22:djae114. doi: 10.1093.
    >> Share


    J Surg Oncol

  34. BENDARI A, Hammoud H, Kumar SK, Harshan M, et al
    Commentary on Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
    J Surg Oncol. 2024 May 22. doi: 10.1002/jso.27669.
    >> Share


    Oncology (Williston Park)

  35. FELDER S, Frakes J, George M, Rosen A, et al
    Which Treatment for Which Patient: Rectal Cancer Management After PROSPECT Trial.
    Oncology (Williston Park). 2024;38:187-190.
    >> Share


    PLoS One

  36. ZAIKA V, Prakash MK, Cheng CY, Schlander M, et al
    Optimal timing of a colonoscopy screening schedule depends on adenoma detection, adenoma risk, adherence to screening and the screening objective: A microsimulation study.
    PLoS One. 2024;19:e0304374.
    >> Share

  37. SU Q, Shen J
    Predictive role of preoperative sarcopenia for long-term survival in rectal cancer patients: A meta-analysis.
    PLoS One. 2024;19:e0303494.
    >> Share


    Proc Natl Acad Sci U S A

  38. YANG C, Dong X, Sun B, Cao T, et al
    Physical immune escape: Weakened mechanical communication leads to escape of metastatic colorectal carcinoma cells from macrophages.
    Proc Natl Acad Sci U S A. 2024;121:e2322479121.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016